Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; University of Cambridge Occupational Health and Safety Service, Cambridge, United Kingdom
Rebecca Ferris
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Chris Workman
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
School of Clinical Medicine, Cambridge, United Kingdom
David A Enoch
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; Clinical Microbiology & Public Health Laboratory, Public Health England, Cambridge, United Kingdom
Emma Goldesgeyme
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Natalie Quinnell
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Parth Patel
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Jo Wright
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Geraldine Martell
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Christine Moody
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Ashley Shaw
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
MRC Biostatistics Unit, Cambridge, United Kingdom; Department of Applied Mathematics and Theoretical Physics, Cambridge, United Kingdom; MRC-University of Glasgow Centre for Virus Research, Scotland, United Kingdom
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; Department of Medicine, University of Cambridge, Cambridge, United Kingdom; Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge, United Kingdom; NHS Blood and Transplant, Cambridge, United Kingdom
Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom; Department of Medicine, University of Cambridge, Cambridge, United Kingdom; Cambridge Institute for Medical Research, Cambridge, United Kingdom
Background: Respiratory protective equipment recommended in the UK for healthcare workers (HCWs) caring for patients with COVID-19 comprises a fluid-resistant surgical mask (FRSM), except in the context of aerosol generating procedures (AGPs). We previously demonstrated frequent pauci- and asymptomatic severe acute respiratory syndrome coronavirus 2 infection HCWs during the first wave of the COVID-19 pandemic in the UK, using a comprehensive PCR-based HCW screening programme (Rivett et al., 2020; Jones et al., 2020). Methods: Here, we use observational data and mathematical modelling to analyse infection rates amongst HCWs working on ‘red’ (coronavirus disease 2019, COVID-19) and ‘green’ (non-COVID-19) wards during the second wave of the pandemic, before and after the substitution of filtering face piece 3 (FFP3) respirators for FRSMs. Results: Whilst using FRSMs, HCWs working on red wards faced an approximately 31-fold (and at least fivefold) increased risk of direct, ward-based infection. Conversely, after changing to FFP3 respirators, this risk was significantly reduced (52–100% protection). Conclusions: FFP3 respirators may therefore provide more effective protection than FRSMs for HCWs caring for patients with COVID-19, whether or not AGPs are undertaken. Funding: Wellcome Trust, Medical Research Council, Addenbrooke’s Charitable Trust, NIHR Cambridge Biomedical Research Centre, NHS Blood and Transfusion, UKRI.